Skip to main content

Upstream Bio, Inc.

UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002022626

In the last 90 days, Upstream Bio, Inc. insiders filed 0 open-market purchases and 5 sales; 148 institutions reported holding it in 13F filings for Q2 2026, worth $350.1M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Upstream Bio, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of UPB: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7983+4
Shares46.3M48.4M+2.07M (+4.5%)
Value$266.9M$530.9M+$264.0M (+98.9%)

New holders (14)

Institutions that held Upstream Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to UPB in Q2 2025
InstitutionSharesValue% of portfolio
Verition Fund Management LLC33,505$367.9K0.00%
American Century Companies Inc22,362$245.5K0.00%
Price T Rowe Associates Inc17,448$192.0K0.00%
Commonwealth Equity Services, LLC15,526$170.0K0.00%
Creative Planning14,030$154.1K0.00%
Manufacturers Life Insurance Company, The13,190$144.8K0.00%
Virtus Investment Advisers, Inc.8,134$89.3K0.03%
Caitong International Asset Management Co., Ltd224$2.46K0.00%
Clearstead Advisors, LLC163$1.79K0.00%
Russell Investments Group, Ltd.147$1.61K0.00%
Essential Partners LLC97$1.06K0.00%
Advisor Group Holdings, Inc.42$2570.00%
Parallel Advisors, LLC2$220.00%
IFP Advisors, Inc1$110.00%

Sold out (10)

Institutions that held Upstream Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of UPB in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Millennium Management LLC61,796$378.2K
EcoR1 Capital, LLC60,000$367.2K
Goldman Sachs Group Inc32,955$201.7K
Two Sigma Investments, LP21,789$133.3K
ADAR1 Capital Management, LLC15,000$91.8K
XTX Topco Ltd12,731$77.9K
Walleye Capital LLC10,000$61.2K
Corebridge Financial, Inc.8,533$52.2K
UMA Financial Services, Inc.69$423
Principal Securities, Inc.12$197